Tumor Necrosis Factor Inhibitors and Lung Disease: A Paradox of Efficacy and Risk
- 1 October 2010
- journal article
- review article
- Published by Elsevier BV in Seminars in Arthritis and Rheumatism
- Vol. 40 (2), 147-163
- https://doi.org/10.1016/j.semarthrit.2009.09.001
Abstract
No abstract availableKeywords
This publication has 102 references indexed in Scilit:
- Role of TNF-α in lung tight junction alteration in mouse model of acute lung inflammationRespiratory Research, 2007
- A New Class of Reverse Signaling Costimulators Belongs to the TNF FamilyThe Journal of Immunology, 2007
- Problems encountered during anti-tumour necrosis factor therapyBest Practice & Research Clinical Rheumatology, 2006
- Apoptosis and Loss of Adhesion of Bronchial Epithelial Cells in AsthmaInternational Archives of Allergy and Immunology, 2005
- Infections Associated with Tumor Necrosis Factor‐α AntagonistsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2005
- In situ localization of TNFα/β, TACE AND TNF receptors TNF-R1 and TNF-R2 in control and LPS-treated lung tissueCytokine, 2003
- Pulmonary Hypoplasia in Mice Lacking Tumor Necrosis Factor-α Converting Enzyme Indicates an Indispensable Role for Cell Surface Protein Shedding during Embryonic Lung Branching MorphogenesisDevelopmental Biology, 2001
- Effects of TNF‐α, IFN‐γ and IL-β on normal human bronchial epithelial cellsEuropean Respiratory Journal, 1999
- A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cellsNature, 1997
- Tumor necrosis factor: Receptor binding and mitogenic action in fibroblastsJournal of Cellular Physiology, 1987